GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 2 filers reported holding GLAXOSMITHKLINE PLC in Q1 2009. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $244,000 | +6.6% | 5,725 | 0.0% | 0.09% | +16.0% |
| Q2 2019 | $229,000 | -81.6% | 5,725 | -80.7% | 0.08% | -75.9% |
| Q1 2019 | $1,242,000 | +467.1% | 29,718 | +419.1% | 0.34% | +394.1% |
| Q4 2018 | $219,000 | -64.0% | 5,725 | -62.2% | 0.07% | -53.1% |
| Q3 2018 | $608,000 | +61.7% | 15,140 | +62.1% | 0.14% | -18.1% |
| Q2 2018 | $376,000 | +3.0% | 9,340 | 0.0% | 0.18% | +2.9% |
| Q1 2018 | $365,000 | -84.2% | 9,340 | -85.7% | 0.17% | -85.7% |
| Q4 2017 | $2,314,000 | +273.8% | 65,240 | +328.1% | 1.20% | +262.2% |
| Q3 2017 | $619,000 | -5.9% | 15,240 | 0.0% | 0.33% | -19.3% |
| Q2 2017 | $658,000 | -14.8% | 15,240 | -16.7% | 0.41% | -19.1% |
| Q1 2017 | $772,000 | -44.2% | 18,300 | -49.2% | 0.51% | -9.3% |
| Q3 2015 | $1,384,000 | -7.7% | 36,000 | 0.0% | 0.56% | +16.0% |
| Q2 2015 | $1,499,000 | -9.8% | 36,000 | 0.0% | 0.48% | +19.9% |
| Q1 2015 | $1,661,000 | -16.7% | 36,000 | -22.8% | 0.40% | +1.8% |
| Q4 2014 | $1,994,000 | -57.0% | 46,645 | -46.3% | 0.40% | -0.8% |
| Q4 2013 | $4,638,000 | -24.7% | 86,871 | -29.2% | 0.40% | -15.5% |
| Q3 2013 | $6,159,000 | -30.5% | 122,771 | -30.8% | 0.47% | -36.7% |
| Q2 2013 | $8,859,000 | +34.4% | 177,295 | +26.2% | 0.74% | +61.0% |
| Q1 2013 | $6,591,000 | +7.9% | 140,495 | 0.0% | 0.46% | -5.5% |
| Q4 2012 | $6,107,000 | -6.0% | 140,495 | 0.0% | 0.49% | -3.0% |
| Q3 2012 | $6,496,000 | +15.0% | 140,495 | +13.3% | 0.50% | +10.0% |
| Q2 2012 | $5,650,000 | +3.1% | 123,995 | +1.6% | 0.46% | +7.0% |
| Q1 2012 | $5,479,000 | -1.6% | 121,995 | 0.0% | 0.43% | -12.3% |
| Q4 2011 | $5,567,000 | -52.4% | 121,995 | -58.0% | 0.49% | -13.2% |
| Q3 2011 | $11,693,000 | -3.0% | 290,490 | -10.4% | 0.56% | +0.4% |
| Q2 2011 | $12,054,000 | +176.5% | 324,190 | +185.6% | 0.56% | +59.1% |
| Q1 2011 | $4,359,000 | -34.6% | 113,495 | -33.2% | 0.35% | -39.8% |
| Q4 2010 | $6,667,000 | -17.0% | 169,995 | -18.5% | 0.58% | -23.3% |
| Q1 2010 | $8,031,000 | -8.8% | 208,495 | 0.0% | 0.76% | -12.2% |
| Q4 2009 | $8,809,000 | +42.2% | 208,495 | +33.0% | 0.87% | +38.2% |
| Q3 2009 | $6,195,000 | +11.8% | 156,795 | 0.0% | 0.63% | -5.7% |
| Q2 2009 | $5,541,000 | +44.1% | 156,795 | +26.7% | 0.67% | +16.6% |
| Q1 2009 | $3,846,000 | – | 123,795 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |